From Name:
From Email:
To Name:
To Email:

Optional Message:


No more unnecessary biopsies? Provista gets $3.9 million for proteomic breast cancer tests

from MedCity News

Without a biopsy, it's difficult to determine whether a woman has breast cancer. But biopsies are costly and invasive, and often — in women with fibrous breast tissue and no cancer — they're actually unnecessary. Scottsdale start-up Provista Diagnostics is developing a way to help diagnose women's cancers more accurately — with just the use of a proteomics-based assay and standard imaging. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063